Certara is a pharmaceutical technology company known for its biosimulation software and drug-development consulting services. The organization employs roughly 550 people across more than twenty offices and remote hubs worldwide. Recent staffing records show 48 new hires and 62 departures, indicating a slight net reduction while overall headcount remains stable. The company continues to balance scientific expertise and commercial operations to support clients in every stage of the drug-development life-cycle.
Engineering is Certara’s largest professional group with about 140 employees, accounting for roughly one-quarter of the global workforce and underscoring the firm’s software-driven business model. Marketing & Product (88 employees) and Business Management (86) form the next-largest cohorts, supporting go-to-market strategy and corporate operations. Sales & Support (75) and Finance & Administration (35) provide client engagement and essential back-office functions, while smaller teams in Legal, Education, Real Estate and other specialty areas round out the organization. Although hiring and departures are spread across multiple groups, the concentration of talent in Engineering and customer-facing roles highlights Certara’s dual focus on product innovation and client service.
Headcount is distributed across a broad geographic footprint. Philadelphia is the single largest listed site with just over 50 employees, followed by the Raleigh-Durham research corridor at around 40. Additional clusters are present in Boston, New York, Princeton, Seattle, Montreal, St. Louis and San Diego, each ranging from 7 to 20 team members. Collectively these offices represent close to half of Certara’s staff, with the remainder working from other regional locations or remote setups, giving the company flexibility to tap into specialized life-sciences talent worldwide.